Variant report

Variant	nsv573329
Chromosome Location	chr16:80980087-80983247
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:9)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:9 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr16:80979777..80982254-chr16:80984998..80987038,2	K562	blood:
2	chr16:80958108..80959131-chr16:80982466..80983464,4	K562	blood:
3	chr16:80957926..80959047-chr16:80982446..80983244,3	MCF-7	breast:
4	chr16:80574553..80575421-chr16:80982567..80983067,2	MCF-7	breast:
5	chr16:80978995..80982254-chr16:80984617..80987394,4	K562	blood:
6	chr16:80958139..80959069-chr16:80982496..80983022,2	MCF-7	breast:
7	chr16:80968184..80971104-chr16:80981792..80984555,2	MCF-7	breast:
8	chr16:80560979..80561850-chr16:80982503..80983251,4	MCF-7	breast:
9	chr16:80499995..80500569-chr16:80982485..80983045,2	MCF-7	breast:

No data

Variant related genes	Relation type
ENSG00000168589	chromatin interactions
ENSG00000259867	chromatin interactions

Extended variants
information (count: 151 )
Associated
traits (count: 71 )

Variant overlapped rSNPs/rCNVs (count:151 , 50 per page) page: 1 2 3 4

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs9652682	chr16:80980087-80980088	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
2	rs576900701	chr16:80980098-80980099	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
3	rs9319560	chr16:80980130-80980131	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
4	rs559516273	chr16:80980142-80980143	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
5	rs186966554	chr16:80980158-80980159	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs143146418	chr16:80980167-80980168	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs563621705	chr16:80980222-80980223	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs530816793	chr16:80980223-80980224	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs191798630	chr16:80980228-80980229	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs9319561	chr16:80980240-80980241	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
11	rs13338281	chr16:80980249-80980250	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs547538405	chr16:80980257-80980258	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs140211562	chr16:80980266-80980267	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs536395853	chr16:80980274-80980275	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs35115578	chr16:80980289-80980290	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
16	rs369743263	chr16:80980293-80980294	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs74028875	chr16:80980305-80980306	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs558154392	chr16:80980310-80980311	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs35436440	chr16:80980311-80980312	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs78295904	chr16:80980312-80980313	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs372027561	chr16:80980348-80980349	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs552747431	chr16:80980372-80980373	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs574473164	chr16:80980385-80980386	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs542085205	chr16:80980392-80980393	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs537961215	chr16:80980402-80980403	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs372336650	chr16:80980406-80980407	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs575636826	chr16:80980424-80980425	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs546090820	chr16:80980470-80980471	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs565295135	chr16:80980473-80980474	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs376925418	chr16:80980477-80980478	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs554635846	chr16:80980479-80980480	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs117639091	chr16:80980492-80980493	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs560013273	chr16:80980528-80980529	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs559635440	chr16:80980554-80980555	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs36079260	chr16:80980607-80980608	Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs529031119	chr16:80980614-80980615	Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs34418099	chr16:80980644-80980645	Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
38	rs373359362	chr16:80980650-80980651	Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs548405223	chr16:80980652-80980653	Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs34297317	chr16:80980693-80980694	Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
41	rs537366428	chr16:80980734-80980735	Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs35031628	chr16:80980761-80980762	Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs552414739	chr16:80980771-80980772	Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs570431838	chr16:80980780-80980781	Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs531218701	chr16:80980781-80980782	Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs534367680	chr16:80980786-80980787	Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs552924608	chr16:80980810-80980811	Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
48	rs573105710	chr16:80980819-80980820	Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs568097374	chr16:80980892-80980893	Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs535519272	chr16:80980958-80980959	Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:71)

Disease	PMID	Source
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Autism	19415332	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Schizophrenia	22958593	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Autism	22495311	CNVD
Wilms tumour	21544195	CNVD
Prostate cancer	18632612	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	17850661	CNVD
Breast cancer	16702952	CNVD
Medulloblastoma	16968546	CNVD
Prostate cancer	19242612	CNVD
Cancer	22429812	CNVD
Ewing''s sarcoma	21437220	CNVD
Ewing''s sarcoma	22429812	CNVD
Melanoma	18172304	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	20837533	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Multiple myeloma	21628407	CNVD
Ovarian cancer	22174824	CNVD
Breast cancer	21858162	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Ewing''s sarcoma	17952124	CNVD
Breast cancer	17001317	CNVD
Breast cancer	17133270	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Breast cancer	17603634	CNVD
Prostate cancer	16573809	CNVD
Prostate cancer	17245344	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Medulloblastoma	16783165	CNVD
Breast cancer	21806811	CNVD
small cell lung cancer	20016488	CNVD
Prostate cancer	21965145	CNVD
Cancer	21183584	CNVD
Ovarian cancer	20844748	CNVD
Lung cancer	18438408	CNVD
Hepatocellular carcinoma	16750200	CNVD
Breast cancer	21509527	CNVD
Breast cancer	21364760	CNVD
Neurocytoma	17123091	CNVD
Central neurocytomas	17123091	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Autism	21865298	CNVD
Myelofibrosis	22110671	CNVD
Non-small cell lung cancer	21829676	CNVD
Neuroblastoma	18923524	CNVD
Lung squamous cell carcinoma	22363434	CNVD
Obesity	20622171	CNVD
Cancer	20164920	CNVD
Chronic lymphocytic leukemia	22228453	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD

Chromatin state (count:65 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr16:80972800-80982600	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
2	chr16:80974800-80986600	Weak transcription	Fetal Adrenal Gland	Adrenal Gland
3	chr16:80979800-80980400	Flanking Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
4	chr16:80980000-80980200	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
5	chr16:80980200-80980600	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
6	chr16:80980200-80981000	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
7	chr16:80980400-80980600	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
8	chr16:80980600-80981000	Flanking Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
9	chr16:80980600-80982000	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
10	chr16:80981000-80981200	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
11	chr16:80981000-80981800	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
12	chr16:80981200-80982800	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
13	chr16:80981200-80983000	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
14	chr16:80981200-80983400	Enhancers	Hela-S3	cervix
15	chr16:80981400-80981800	Enhancers	Primary neutrophils fromperipheralblood	blood
16	chr16:80981400-80981800	Enhancers	Brain Dorsolateral Prefrontal Cortex	brain
17	chr16:80981400-80982400	Enhancers	Brain Cingulate Gyrus	brain
18	chr16:80981400-80982400	Enhancers	Brain Hippocampus Middle	brain
19	chr16:80981400-80983000	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
20	chr16:80981600-80982400	Enhancers	Brain Angular Gyrus	brain
21	chr16:80981600-80983000	Enhancers	Esophagus	oesophagus
22	chr16:80981600-80983200	Enhancers	Brain Anterior Caudate	brain
23	chr16:80981600-80983200	Enhancers	Brain Substantia Nigra	brain
24	chr16:80981800-80982800	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
25	chr16:80981800-80982800	Weak transcription	Brain Dorsolateral Prefrontal Cortex	brain
26	chr16:80981800-80984600	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
27	chr16:80982000-80982600	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
28	chr16:80982000-80983200	Enhancers	HUVEC	blood vessel
29	chr16:80982200-80982400	Enhancers	Brain Inferior Temporal Lobe	brain
30	chr16:80982200-80983000	Enhancers	Stomach Mucosa	stomach
31	chr16:80982400-80982800	Flanking Active TSS	Brain Cingulate Gyrus	brain
32	chr16:80982400-80982800	Flanking Active TSS	Brain Inferior Temporal Lobe	brain
33	chr16:80982400-80982800	Enhancers	Right Ventricle	heart
34	chr16:80982400-80983000	Flanking Active TSS	Brain Hippocampus Middle	brain
35	chr16:80982400-80983200	Enhancers	ES-I3 Cell Line	embryonic stem cell
36	chr16:80982400-80983200	Enhancers	H1 Cell Line	embryonic stem cell
37	chr16:80982400-80983200	Enhancers	HUES48 Cell Line	embryonic stem cell
38	chr16:80982400-80983200	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
39	chr16:80982600-80982800	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
40	chr16:80982600-80983200	Enhancers	Gastric	stomach
41	chr16:80982600-80983200	Bivalent Enhancer	Skeletal Muscle Male	skeletal muscle
42	chr16:80982600-80983200	Enhancers	NHEK	skin
43	chr16:80982600-80983600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
44	chr16:80982800-80983000	Enhancers	Brain Cingulate Gyrus	brain
45	chr16:80982800-80983200	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
46	chr16:80982800-80983200	Enhancers	Brain Inferior Temporal Lobe	brain
47	chr16:80982800-80983200	Enhancers	Psoas Muscle	Psoas
48	chr16:80983000-80983200	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
49	chr16:80983000-80983200	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
50	chr16:80983000-80983200	Flanking Bivalent TSS/Enh	HUES6 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links